Insight Partners is an awesome firm that shares many of our values, and we’ve been grateful to have them as partners on this journey of building a great company based on a great product.
Eran Zinman Co-Founder & CEO Monday.com*
London, No Data Available, U.K.
Lehi, Utah, U.S.
Farmington, Utah, U.S.
San Francisco, California, U.S.
Wilmington, North Carolina, U.S.
San Francisco, California, U.S.
Limerick, No Data Available, Ireland
Amsterdam, No Data Available, Netherlands
Tel Aviv, No Data Available, Israel
Bonn, No Data Available, Germany
Miami, Florida, U.S.
San Francisco, California, U.S.
Insight Partners is an awesome firm that shares many of our values, and we’ve been grateful to have them as partners on this journey of building a great company based on a great product.
Unlearn.AI is the only company creating TwinRCTs™, which combine AI, digital twins, and novel statistical methods to enable smaller, more efficient clinical trials. Unlearn’s technology has been published in conference abstracts and scientific journals, including Scientific Reports - Nature and The International Journal of Biostatistics. Unlearn is partnering with the world’s leading pharma companies, including Merck KGaA, Darmstadt, Germany, and continues to have discussions with regulators. The European Medicines Agency (EMA) published a draft qualification opinion for PROCOVA™ — a patent-pending method developed by Unlearn for leveraging historical data and machine learning to reduce sample sizes or increase power in Phase 2 or 3 clinical trials. For more information, please visit https://www.unlearn.ai or follow @UnlearnAI on Twitter, @unlearn-ai on LinkedIn.
